Vertical Pharmaceuticals, LLC FDA Inspection Record

FEI 3004421212 · Inspections, Form 483s, warning letters and import refusals

Vertical Pharmaceuticals, LLC is an FDA-inspected facility (FEI 3004421212) located in Sayreville, NJ, US. RegDataLab tracks 6 FDA inspections and 2 compliance actions at this facility.

What FDA found at this site

Latest inspection
Sep 26, 2023: No Action Indicated (NAI)
Inspections on record
6 (2 OAI, 2 VAI, 2 NAI)
Last OAI inspection
Nov 1, 2016
Warning letters
2 listed by FDA for this FEI, latest May 10, 2017
Recalls as the recalling firm
1, latest Dec 21, 2010

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Sep 26, 2023No Action Indicated (NAI)No citations listed
Sep 25, 2019No Action Indicated (NAI)No citations listed
Jul 18, 2018Voluntary Action Indicated (VAI)Late submission of quarterly safety reports (21 CFR 314.80(c)(2))
Nov 1, 2016Official Action Indicated (OAI)Failure to review ADE information (21 CFR 314.80(b))
Failure to develop written procedures (21 CFR 314.80(b))
Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Interval (21 CFR 314.80(c)(2))
and 1 more
Dec 20, 2010Voluntary Action Indicated (VAI)No citations listed
Feb 24, 2010Official Action Indicated (OAI)Training--operations, GMPs, written procedures (21 CFR 211.25(a))
Review of representative number of batches (21 CFR 211.180(e)(1))
Written procedures lacking for use of pesticides etc. (21 CFR 211.56(c))
Approval and review of procedures (21 CFR 211.100(a))
and 2 more

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Dec 21, 2010Class IIID-247-2011OB Complete 400; Prenatal Vitamin with DHA, Softgel capsules; 30 count package; Rx only… and 3 more products
Defective Delivery System: Product may contain leaking capsules.

FDA record score

9 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Warning letter on FDA's dashboard, which does not show close-outsMay 10, 201730 x 0.257.5
Inspection classified VAIJul 18, 20186 x 0.251.5
Inspection classified OAINov 1, 201610 years or older, so it adds no points0
Inspection classified VAIDec 20, 201010 years or older, so it adds no points0
Inspection classified OAIFeb 24, 201010 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsFeb 18, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Vertical Pharmaceuticals, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Vertical Pharmaceuticals, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Vertical Pharmaceuticals, LLC
Location
Sayreville, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.